Erisipelas and its Management in a Tertiary Care Hospital

Erysipelas is an acute dermo-hypodermic (non-necrotizing) infection of bacterial origin, mainly group A beta-hemolytic streptococcus. The lower limbs are affected in more than 80% cases and the risk factors identified skin barrier breakdown, lymphedema obesity. Diagnosis clinical based on association inflammatory plaque with fever, lymphangitis, lymphadenopathy leukocytosis. Bacteriology generally not useful due to low sensitivity or late positivity. In atypical forms, erysipelas should be distinguished from necrotizing fasciitis venous thrombosis. Penicillin remains gold standard treatment, although new drugs may used, given their pharmacodynamic profile. Recurrence main complication, being crucial correct treatment factors1.